Abstract
Nivolumab in Combination with Gemcitabine and Oxaliplatin (GemOx) in Relapse/Refractory T-Cell Lymphoma: Preliminary Results of the Experimental Arm of the Niveau Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have